Arrhythmia Research Technology (HRT) Widens Q2 Loss to 37c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Arrhythmia Research Technology (AMEX: HRT) reported Q2 EPS of ($0.37), versus ($0.09) reported last year. Revenue for the quarter came in at $4.98 million, versus $6.02 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phoenix Education Partners (PXED) PT Lowered to $32 at Jefferies
- Alphabet stock jumps as buyers return after selloff
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
